Treato is a Yehud, Israel-based provider of social health patient intelligence solutions. Led by CEO Ido Hadari, the company combines patented Natural Language Processing algorithms, patient language dictionaries and Big Data analytics to deliver real-time patient insights from social media. Its consumer-facing website offers drug and condition information for patients, while Treato Pharma delivers subscription-based patient analytics for pharmaceutical professionals. Treato Pharma enables monitoring of competitive position, understanding reasons behind drug switching behavior and uncovering adherence obstacles. To date the platform has aggregated and analyzed more than 1.3 billion patient conversations about 24,000 drugs and conditions from thousands of sites. The company secured $14.5M in funding to support its operations and growth.

Total raised

$15M

Funding rounds

1

Latest round

Equity

Latest activity

Apr 2013